Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolization

作者：Dongdong Xia, Qiuhe Wang, Wei Bai, Enxin Wang, Zhexuan Wang, Wei Mu, Junhui Sun, Ming Huang, Guowen Yin, H. Li, Hui Zhao, Chunqing Zhang, Jing Li, Jianbing Wu, Xiaoli Zhu, Shufa Yang, Xingnan Pan, Jiaping Li, Zixiang Li, Guohui Xu, Hai‐Bin Shi, Hui Zhang, Yuelin Zhang, Rong Ding, Hui Yu, Zheng Lin, Xiaohu Yang, Guangchuan Wang, Nan You, Long Feng, Shuai Zhang, Wukui Huang, Tao Xu, Wenzhe Fan, Xueda Li, Xuegang Yang, Wei-Zhong Zhou, Wenjun Wang, Xiaomei Li, Zhenyu Wang, Bohan Luo, Jing Niu, Jie Yuan, Yong Lv, Kai Li, Wengang Guo, Zhanxin Yin, Daiming Fan, Jielai Xia, Guohong Han, on behalf of China HCC-TACE Study Group · 发表于：European Radiology · 年份：2022 · DOI：10.1007/s00330-022-08716-4 · 被引用次数：15 · 研究领域：Hepatocellular Carcinoma Treatment and Prognosis、Cholangiocarcinoma and Gallbladder Cancer Studies、Management of metastatic bone disease